All articles by Anne Charlotte Ackermann
Anne Charlotte Ackermann
New pricing rules lower access barriers for orphan drugs in France
A new “flat-rate payment” system may likely be very common for upcoming orphan medicines in France.
New Covid-19 antivirals priced reasonably according to ICER
ICER’s assessment is extremely unusual, since only 10% of reviewed drugs fell within ICER’s cost-effectiveness threshold, as per a GlobalData analysis.
Pricing and Market Access Trends: 2022 Outlook
As we start 2022, the global market access environment has reached an unprecedented high level of risk.